WHITEHAWK THERAPEUTICS, INC. Paid-in-Kind Interest
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Paid-in-Kind Interest of $204.93 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2019-03-07
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2017-12-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2017-06-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for the quarter ending 2017-03-31 was $204.93K.
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for fiscal 2017 was $204.93K, a 7159.26% increase from fiscal 2016.
- WHITEHAWK THERAPEUTICS, INC. paid-in-kind interest for fiscal 2016 was $2.82K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $204.93K 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $204.93K 10-Q · filed 2018-11-07 | -$50.25K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $204.93K 10-Q · filed 2018-08-14 | -$50.25K derived: sum of 3 quarters · filed 2018-08-14 | $117.79K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $204.93K 10-Q · filed 2018-05-15 | -$50.25K derived: sum of 2 quarters · filed 2018-05-15 | $117.79K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$255.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$87.14K derived: sum of 2 quarters · filed 2018-03-15 | $2.82K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $168.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $258.00K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $89.96K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |